| Members |
targetComponentId |
| 15 year examination |
Child 15 year examination (procedure) |
| 16-dehydroprogesterone hydratase |
16-alpha-hydroxyprogesterone dehydratase |
| 17-Beta-estriol |
Estradiol |
| 18-Hydroxydeoxycortisol measurement |
18-Hydroxycortisol measurement |
| 1q partial trisomy syndrome |
Partial trisomy of long arm of chromosome 1 (disorder) |
| 1q partial trisomy syndrome |
Trisomy 1q syndrome (disorder) |
| 2,2-Dichloro-1,1-difluoroethylmethyl ether |
Methoxyflurane |
| 2-Thio,4-Carboxythiazolidine |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid |
| 2-Thio,4-carboxythiazolidine measurement |
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid measurement (procedure) |
| 21q partial trisomy syndrome |
21q partial trisomy (disorder) |
| 21q partial trisomy syndrome |
21q partial distal trisomy (disorder) |
| 22q11 microdeletion with complete DiGeorge sequence |
22q11.2 deletion syndrome (disorder) |
| 24 hour urine volume (& level) |
24 hour urine sample volume measurement |
| 24 hour urine volume (& level) |
24 hour urine volume - finding |
| 3 Buck shot, device |
Shotgun shot |
| 3 Buck shot, device |
Shot size |
| 3 day faecal fat estimation (& level) |
3 day faecal fat estimation |
| 3,4 Methylhippurate |
Para-methyl hippurate (substance) |
| 3,4-Methylhippurate measurement |
para-Methyl hippurate measurement (procedure) |
| 3-Hydroxybutylcarnitine |
3-hydroxybutyrylcarnitine (substance) |
| 3-Hydroxybutylcarnitine measurement |
3-hydroxybutyrylcarnitine measurement |
| 3-tree-Pharmacia pollen mix |
Tree pollen (substance) |
| 3-tree-Pharmacia pollen mix allergen |
Tree pollen (substance) |
| 3/4 crown |
Crown |
| 30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 30-39 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 40-49 percent of body surface |
| 30-50% body burnt |
Burn any degree involving 50-59 percent of body surface |
| 4 Buck shot, device |
Shotgun shot |
| 4 Buck shot, device |
Shot size |
| 4,5-Dihydroxyhexanolactone |
4,5-dihydroxyhexanoate (substance) |
| 4-Allylmethoxy-2-phenol |
Eugenol |
| 4-Hydroxyphenylpyruvate dioxygenase deficiency |
Tyrosinemia type III (disorder) |
| 4-Hydroxyphenylpyruvate dioxygenase deficiency |
4-Hydroxyphenylpyruvate dioxygenase deficiency (disorder) |
| 4-Hydroxyphenylpyruvate dioxygenase deficiency |
Hawkinsinuria (disorder) |
| 4-quinolones overdose |
Quinolone antibacterial overdose |
| 4-quinolones overdose of undetermined intent |
Quinolone antibacterial overdose |
| 4-quinolones poisoning |
Fluoroquinolone poisoning (disorder) |
| 4-quinolones poisoning of undetermined intent |
Fluoroquinolone poisoning (disorder) |
| 5-OH indole acetic acid (& level (& urine)) |
5-Hydroxyindoleacetic acid measurement, quantitative, urine |
| 5-OH indole acetic acid (& level (& urine)) |
5-hydroxyindole acetic acid (substance) |
| 5-OH indole acetic acid (& level (& urine)) |
5-hydroxyindole acetic acid (substance) |
| 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) |
5-chloro-2-methyl-4-isothiazolin-3-one (substance) |
| 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one kathon (3:1 in water) |
2-methyl-4-isothiazolin-3-one |
| 50-70% body burnt |
Burn any degree involving 60-69 percent of body surface |
| 50-70% body burnt |
Burn any degree involving 60-69 percent of body surface |
| 50-70% body burnt |
Burn any degree involving 70-79 percent of body surface |
| 50-70% body burnt |
Burn any degree involving 50-59 percent of body surface |
| 50-70% body burnt |
Burn any degree involving 70-79 percent of body surface |
| 50-70% body burnt |
Burn any degree involving 50-59 percent of body surface |
| 6 mm caliber bullet, device |
Bullet |
| 6-grass Pharmacia pollen mix |
Grass pollen |
| 6-grass Pharmacia pollen mix allergen |
Grass pollen |
| 6.5 mm caliber bullet, device |
Bullet |
| 60-80% of predicted peak flow rate (& expiratory) |
60 to 80 percent of predicted peak expiratory flow rate |
| 7 mm caliber bullet, device |
Bullet |
| 7/8 crown |
Crown |
| 8 mm caliber bullet, device |
Bullet |
| 8p partial trisomy syndrome |
Trisomy 8p syndrome (disorder) |
| 8p partial trisomy syndrome |
Partial trisomy of short arm of chromosome 8 |
| 9 mm caliber bullet, device |
Bullet |
| 9p partial monosomy syndrome |
Monosomy 9p |
| A |
Abdominal lymph node tumor invasion status A (tumor staging) |
| A |
Upper case Roman letter A (qualifier value) |
| A/B cover need - surg./dentist |
Requires antibiotic coverage for surgical procedure (finding) |
| A/B cover need - surg./dentist |
Requires antibiotic coverage for dental procedure |
| A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for surgical procedure (finding) |
| A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for dental procedure |
| A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for surgical procedure (finding) |
| A/B cover need - surgery &/or dentist |
Requires antibiotic coverage for dental procedure |
| A/N U/S scan for ? abnormality |
Antenatal ultrasound scan for possible abnormality (procedure) |
| A/N U/S scan normal +? dates |
Antenatal ultrasound scan normal and possibly inconsistent with estimated date of delivery (finding) |
| A/N amnio. for ? chrom.abnorm. |
Amniocentesis for possible chromosomal abnormality (procedure) |
| A/N amnio. for ? neural tube |
Amniocentesis for possible neural tube defect (procedure) |
| AA amyloidosis |
AA amyloidosis |
| ACE inhibitor-aggravated angioedema-urticaria (disorder) |
ACE inhibitor-aggravated angioedema |
| ACTH deficiency |
Isolated corticotropin deficiency |
| ACTH deficiency |
ACTH deficiency |
| AD type amyloidosis |
Amyloidosis of skin |
| AD type amyloidosis |
Senile brain amyloidosis (disorder) |
| AIDS with Burkitt's tumor |
Burkitt lymphoma co-occurrent with human immunodeficiency virus infection (disorder) |
| AIDS with CNS demyelinating disease |
Central nervous system demyelinating disease with acquired immunodeficiency syndrome (disorder) |
| AIDS with Kaposi's sarcoma |
Kaposi's sarcoma with AIDS (acquired immunodeficiency syndrome) |
| AIDS with Nocardia infection |
Nocardiosis with acquired immunodeficiency syndrome (disorder) |
| AIDS with abnormal weight loss |
Abnormal weight loss associated with AIDS |
| AIDS with acquired hemolytic anemia |
Acquired haemolytic anaemia associated with AIDS |
| AIDS with acute endocarditis |
Acute endocarditis with AIDS (acquired immunodeficiency syndrome) |
| AIDS with acute myocarditis |
Myocarditis with acquired immunodeficiency syndrome (disorder) |
| AIDS with agranulocytosis |
Agranulocytosis with acquired immunodeficiency syndrome (disorder) |
| AIDS with anemia |
Anemia associated with AIDS |
| AIDS with aplastic anemia |
Aplastic anemia with AIDS (acquired immunodeficiency syndrome) |
| AIDS with background retinopathy |
Retinopathy with acquired immunodeficiency syndrome (disorder) |
| AIDS with bacterial pneumonia |
Bacterial pneumonia with AIDS (acquired immunodeficiency syndrome) |
| AIDS with blindness |
Blindness with AIDS (acquired immunodeficiency syndrome) |
| AIDS with cachexia |
Cachexia associated with AIDS |
| AIDS with candidiasis of lung |
Candidiasis of lung with AIDS (acquired immunodeficiency syndrome) |
| AIDS with candidiasis of mouth |
Candidiasis of mouth with acquired immunodeficiency syndrome (disorder) |
| AIDS with candidiasis of skin AND/OR nails |
Candidal paronychia |
| AIDS with central nervous system disorder |
Central nervous disorder with AIDS (acquired immunodeficiency syndrome) |
FHIR